Search details
1.
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations.
Nat Immunol
; 22(12): 1503-1514, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34716452
2.
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
J Virol
; 97(7): e0159622, 2023 07 27.
Article
in English
| MEDLINE | ID: mdl-37395646
3.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
Proc Natl Acad Sci U S A
; 118(38)2021 09 21.
Article
in English
| MEDLINE | ID: mdl-34470866
4.
Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
Cytotherapy
; 20(3): 407-419, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29306566
5.
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.
Nat Commun
; 15(1): 3924, 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38724518
6.
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.
Lancet Microbe
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38761816
7.
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.
Structure
; 32(2): 131-147.e7, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38157856
8.
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
Nat Commun
; 15(1): 200, 2024 Jan 03.
Article
in English
| MEDLINE | ID: mdl-38172512
9.
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques.
Cell Rep Med
; 4(4): 101018, 2023 04 18.
Article
in English
| MEDLINE | ID: mdl-37023746
10.
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity.
Nat Commun
; 14(1): 580, 2023 02 03.
Article
in English
| MEDLINE | ID: mdl-36737435
11.
Production and Characterization of SIV-Specific CAR/CXCR5 T Cells.
Methods Mol Biol
; 2421: 171-185, 2022.
Article
in English
| MEDLINE | ID: mdl-34870819
12.
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model.
Vaccines (Basel)
; 10(5)2022 May 04.
Article
in English
| MEDLINE | ID: mdl-35632473
13.
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN.
Sci Adv
; 8(47): eade4433, 2022 Nov 25.
Article
in English
| MEDLINE | ID: mdl-36417525
14.
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates.
Sci Transl Med
; 14(632): eabi5735, 2022 Feb 16.
Article
in English
| MEDLINE | ID: mdl-34914540
15.
In vitro evolution of ligands to the membrane protein caveolin.
J Am Chem Soc
; 133(25): 9855-62, 2011 Jun 29.
Article
in English
| MEDLINE | ID: mdl-21615158
16.
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamsters.
bioRxiv
; 2021 Jun 16.
Article
in English
| MEDLINE | ID: mdl-34159328
17.
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates.
bioRxiv
; 2021 Mar 25.
Article
in English
| MEDLINE | ID: mdl-33791694
18.
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques.
bioRxiv
; 2021 Apr 10.
Article
in English
| MEDLINE | ID: mdl-33851155
19.
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.
Cell Rep
; 37(12): 110143, 2021 12 21.
Article
in English
| MEDLINE | ID: mdl-34919799
20.
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
NPJ Vaccines
; 6(1): 129, 2021 Oct 28.
Article
in English
| MEDLINE | ID: mdl-34711815